Literature DB >> 25471334

Interaction of green tea catechins with breast cancer endocrine treatment: a systematic review.

Eugenia C Yiannakopoulou1.   

Abstract

Recent data have shown strong chemopreventive and possibly cancer chemotherapeutic effects of green tea polyphenols and EGCG against breast cancer. This systematic review aims to synthesize data on the possible interaction of green tea catechins with breast cancer endocrine treatment. Electronic databases were searched with the appropriate search terms. Experimental trials suggest a synergistic interaction of green tea catechins with tamoxifen or raloxifene in the treatment of estrogen receptor-positive and estrogen receptor-negative breast cancer through estrogen receptor-dependent and -independent mechanisms. No evidence of an interaction of green tea catechins with aromatase inhibitors or fulvestrant has been reported. As green tea catechins are natural compounds with a rather favorable safety profile, the strategy of co-administrating green tea catechins with tamoxifen seems to be a rational approach in chemoprevention, adjuvant and metastatic breast cancer treatment that needs further investigation.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25471334     DOI: 10.1159/000369170

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  10 in total

Review 1.  The potential contribution of dietary factors to breast cancer prevention.

Authors:  Niva Shapira
Journal:  Eur J Cancer Prev       Date:  2017-09       Impact factor: 2.497

2.  EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.

Authors:  Fulvia Farabegoli; Marzia Govoni; Enzo Spisni; Alessio Papi
Journal:  Biosci Rep       Date:  2017-05-17       Impact factor: 3.840

Review 3.  Breast cancer chemopreventive and chemotherapeutic effects of Camellia Sinensis (green tea): an updated review.

Authors:  Mahmoud Rafieian-Kopaei; Mino Movahedi
Journal:  Electron Physician       Date:  2017-02-25

4.  Green Tea Consumption and Risk of Breast Cancer and Recurrence-A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Vincenza Gianfredi; Daniele Nucci; Angela Abalsamo; Mattia Acito; Milena Villarini; Massimo Moretti; Stefano Realdon
Journal:  Nutrients       Date:  2018-12-03       Impact factor: 5.717

5.  Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database.

Authors:  Stéphanie Pochet; Anne-Sophie Lechon; Cécile Lescrainier; Carine De Vriese; Véronique Mathieu; Jamila Hamdani; Florence Souard
Journal:  Sci Rep       Date:  2022-08-19       Impact factor: 4.996

6.  Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro.

Authors:  Mª Jesús Núñez-Iglesias; Silvia Novio; Carlota García; Mª Elena Pérez-Muñuzuri; María-Carmen Martínez; José-Luis Santiago; Susana Boso; Pilar Gago; Manuel Freire-Garabal
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

7.  Tea consumption and breast cancer risk in a cohort of women with family history of breast cancer.

Authors:  Dongyu Zhang; Hazel B Nichols; Melissa Troester; Jianwen Cai; Jeannette T Bensen; Dale P Sandler
Journal:  Int J Cancer       Date:  2020-02-04       Impact factor: 7.316

8.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Tommaso Filippini; Marcella Malavolti; Francesca Borrelli; Angelo A Izzo; Susan J Fairweather-Tait; Markus Horneber; Marco Vinceti
Journal:  Cochrane Database Syst Rev       Date:  2020-03-02

9.  Regulation of Mucin 1 and multidrug resistance protein 1 by honokiol enhances the efficacy of doxorubicin-mediated growth suppression in mammary carcinoma cells.

Authors:  Padmamalini Thulasiraman; Andrea Butts Johnson
Journal:  Int J Oncol       Date:  2016-05-23       Impact factor: 5.650

Review 10.  Polyphenols as Promising Drugs against Main Breast Cancer Signatures.

Authors:  María Losada-Echeberría; María Herranz-López; Vicente Micol; Enrique Barrajón-Catalán
Journal:  Antioxidants (Basel)       Date:  2017-11-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.